{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T15:42:18Z","timestamp":1792510938202,"version":"4.5.0"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T00:00:00Z","timestamp":1770595200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Forschung, Technologie und Raumfahrt","doi-asserted-by":"publisher","award":["01GR2303"],"award-info":[{"award-number":["01GR2303"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","maturitas.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Maturitas"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.maturitas.2026.108870","type":"journal-article","created":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T07:56:11Z","timestamp":1770364571000},"page":"108870","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Functional testosterone deficiency in aging men: Clinical impact, diagnostic pathways, and treatment strategies"],"prefix":"10.1016","volume":"207","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3629-7160","authenticated-orcid":false,"given":"Michael","family":"Zitzmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armin","family":"Soave","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Bier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.maturitas.2026.108870_bb0005","series-title":"EAU-Guidelines-on-Sexual-and-Reproductive-Health-2025.pdf","author":"Salonia","year":"2025"},{"issue":"5","key":"10.1016\/j.maturitas.2026.108870_bb0010","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1111\/andr.12770","article-title":"European academy of andrology (EAA) guidelines on investigation, treatment and monitoring of functional hypogonadism in males","volume":"8","author":"Corona","year":"2020","journal-title":"Andrology"},{"issue":"5","key":"10.1016\/j.maturitas.2026.108870_bb0015","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1210\/jc.2018-00229","article-title":"Testosterone therapy in men with hypogonadism: an Endocrine Society clinical practice guideline","volume":"103","author":"Bhasin","year":"2018","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"12","key":"10.1016\/j.maturitas.2026.108870_bb0020","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/nrendo.2009.212","article-title":"Testosterone deficiency, insulin resistance and the metabolic syndrome","volume":"5","author":"Zitzmann","year":"2009","journal-title":"Nat. Rev. Endocrinol."},{"issue":"10","key":"10.1016\/j.maturitas.2026.108870_bb0025","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0109346","article-title":"A validated age-related normative model for male total testosterone shows increasing variance but no decline after age 40 years","volume":"9","author":"Kelsey","year":"2014","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.maturitas.2026.108870_bb0030","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1007\/s40618-024-02319-0","article-title":"Novel reference range values for serum testosterone: a cross-sectional study of 200,000 males","volume":"47","author":"Fantus","year":"2024","journal-title":"J. Endocrinol. Investig."},{"issue":"11","key":"10.1016\/j.maturitas.2026.108870_bb0035","doi-asserted-by":"crossref","first-page":"4335","DOI":"10.1210\/jc.2006-0401","article-title":"Association of specific symptoms and metabolic risks with serum testosterone in older men","volume":"91","author":"Zitzmann","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6","key":"10.1016\/j.maturitas.2026.108870_bb0040","doi-asserted-by":"crossref","first-page":"768","DOI":"10.7326\/M23-2781","article-title":"Associations of testosterone and related hormones with all-cause and cardiovascular mortality and incident cardiovascular disease in men: individual participant data Meta-analyses","volume":"177","author":"Yeap","year":"2024","journal-title":"Ann. Intern. Med."},{"issue":"1","key":"10.1016\/j.maturitas.2026.108870_bb0045","doi-asserted-by":"crossref","DOI":"10.1080\/13685538.2025.2519035","article-title":"Recommendations for diagnosis and treatment of the aging male with Klinefelter syndrome","volume":"28","author":"Zitzmann","year":"2025","journal-title":"Aging Male"},{"issue":"1","key":"10.1016\/j.maturitas.2026.108870_bb0050","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/andr.12909","article-title":"European academy of andrology guidelines on Klinefelter syndrome endorsing organization: European society of endocrinology","volume":"9","author":"Zitzmann","year":"2021","journal-title":"Andrology"},{"issue":"7","key":"10.1016\/j.maturitas.2026.108870_bb0055","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.mayocp.2016.04.007","article-title":"Fundamental concepts regarding testosterone deficiency and treatment: international expert consensus resolutions","volume":"91","author":"Morgentaler","year":"2016","journal-title":"Mayo Clin. Proc."},{"issue":"8","key":"10.1016\/j.maturitas.2026.108870_bb0060","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1210\/jc.2011-0118","article-title":"Low testosterone in men with type 2 diabetes: significance and treatment","volume":"96","author":"Grossmann","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.maturitas.2026.108870_bb0065","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s12958-025-01425-9","article-title":"Short-term impact of tirzepatide on metabolic hypogonadism and body composition in patients with obesity: a controlled pilot study","volume":"23","author":"La Vignera","year":"2025","journal-title":"Reprod. Biol. Endocrinol."},{"issue":"8","key":"10.1016\/j.maturitas.2026.108870_bb0070","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1016\/j.jsxm.2016.05.010","article-title":"Demographic and clinical correlates of patient-reported improvement in sex drive, erectile function, and energy with testosterone solution 2%","volume":"13","author":"Wu","year":"2016","journal-title":"J. Sex. Med."},{"issue":"7","key":"10.1016\/j.maturitas.2026.108870_bb0075","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1056\/NEJMoa1506119","article-title":"Effects of testosterone treatment in older men","volume":"374","author":"Snyder","year":"2016","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.maturitas.2026.108870_bb0080","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S2213-8587(20)30367-3","article-title":"Testosterone treatment to prevent or revert type 2 diabetes in men enrolled in a lifestyle programme (T4DM): a randomised, double-blind, placebo-controlled, 2-year, phase 3b trial","volume":"9","author":"Wittert","year":"2021","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"4","key":"10.1016\/j.maturitas.2026.108870_bb0085","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1001\/jamainternmed.2016.9540","article-title":"Association of Testosterone Levels with Anemia in older men: a controlled clinical trial","volume":"177","author":"Roy","year":"2017","journal-title":"JAMA Intern. Med."},{"issue":"3","key":"10.1016\/j.maturitas.2026.108870_bb0090","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1210\/er.2017-00234","article-title":"Lessons from the testosterone trials","volume":"39","author":"Snyder","year":"2018","journal-title":"Endocr. Rev."},{"issue":"1","key":"10.1016\/j.maturitas.2026.108870_bb0095","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1080\/13685538.2022.2063830","article-title":"The HEAT-registry (HEmatopoietic affection by testosterone): comparison of a transdermal gel vs long-acting intramuscular testosterone undecanoate in hypogonadal men","volume":"25","author":"Zitzmann","year":"2022","journal-title":"Aging Male"},{"key":"10.1016\/j.maturitas.2026.108870_bb0100","article-title":"Testosterone deficiency and chronic kidney disease","volume":"37","author":"Zitzmann","year":"2024","journal-title":"J. Clin. Transl. Endocrinol."},{"issue":"4","key":"10.1016\/j.maturitas.2026.108870_bb0105","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1001\/jamainternmed.2016.9539","article-title":"Effect of testosterone treatment on volumetric bone density and strength in older men with low testosterone: a controlled clinical trial","volume":"177","author":"Snyder","year":"2017","journal-title":"JAMA Intern. Med."},{"issue":"4","key":"10.1016\/j.maturitas.2026.108870_bb0110","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1530\/EJE-13-0321","article-title":"Testosterone deficiency is associated with increased risk of mortality and testosterone replacement improves survival in men with type 2 diabetes","volume":"169","author":"Muraleedharan","year":"2013","journal-title":"Eur. J. Endocrinol."},{"issue":"5","key":"10.1016\/j.maturitas.2026.108870_bb0115","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1080\/14740338.2024.2337741","article-title":"Cardiovascular safety of testosterone replacement therapy in men: an updated systematic review and meta-analysis","volume":"23","author":"Corona","year":"2024","journal-title":"Expert Opin. Drug Saf."},{"issue":"2","key":"10.1016\/j.maturitas.2026.108870_bb0120","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1056\/NEJMoa2215025","article-title":"Cardiovascular Safety of testosterone-replacement therapy","volume":"389","author":"Lincoff","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.maturitas.2026.108870_bb0125","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1093\/sxmrev\/qeae062","article-title":"Newer formulations of oral testosterone undecanoate: development and liver side effects","volume":"13","author":"Goldstein","year":"2025","journal-title":"Sex Med Rev."},{"issue":"4","key":"10.1016\/j.maturitas.2026.108870_bb0130","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1111\/andr.13747","article-title":"Safety, efficacy, and pharmacokinetics of oral testosterone undecanoate in males with hypogonadism","volume":"13","author":"Miner","year":"2025","journal-title":"Andrology"},{"issue":"3","key":"10.1016\/j.maturitas.2026.108870_bb0135","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1080\/17446651.2023.2197059","article-title":"Novel methods for the treatment of low testosterone","volume":"18","author":"Fink","year":"2023","journal-title":"Expert. Rev. Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.maturitas.2026.108870_bb0140","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.juro.2018.09.057","article-title":"A 52-week study of dose adjusted subcutaneous testosterone Enanthate in oil self-administered via disposable auto-injector","volume":"201","author":"Kaminetsky","year":"2019","journal-title":"J. Urol."},{"issue":"1","key":"10.1016\/j.maturitas.2026.108870_bb0145","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/cen.13164","volume":"86","author":"Rohayem","year":"2017","journal-title":"Clin. Endocrinol."},{"issue":"3","key":"10.1016\/j.maturitas.2026.108870_bb0150","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1210\/jc.2008-1648","article-title":"Induction of spermatogenesis and fertility during gonadotropin treatment of gonadotropin-deficient infertile men: predictors of fertility outcome","volume":"94","author":"Liu","year":"2009","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.maturitas.2026.108870_bb0155","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.beem.2013.07.004","article-title":"Effects of age on male fertility","volume":"27","author":"Zitzmann","year":"2013","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"issue":"11","key":"10.1016\/j.maturitas.2026.108870_bb0160","doi-asserted-by":"crossref","DOI":"10.1210\/jendso\/bvae164","article-title":"Fundamental body composition principles provide context for fat-free and skeletal muscle loss with GLP-1 RA treatments","volume":"8","author":"Tinsley","year":"2024","journal-title":"J. Endocr. Soc."},{"issue":"12","key":"10.1016\/j.maturitas.2026.108870_bb0165","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.48692","article-title":"Prostate safety events during testosterone replacement therapy in men with hypogonadism: a randomized clinical trial","volume":"6","author":"Bhasin","year":"2023","journal-title":"JAMA Netw. Open"},{"issue":"5","key":"10.1016\/j.maturitas.2026.108870_bb0170","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1530\/EJE-11-0221","article-title":"Onset of effects of testosterone treatment and time span until maximum effects are achieved","volume":"165","author":"Saad","year":"2011","journal-title":"Eur. J. Endocrinol."},{"issue":"3","key":"10.1016\/j.maturitas.2026.108870_bb0175","first-page":"xx","article-title":"Cardiovascular safety of testosterone therapy \u2013 insights from the TRAVERSE trial and beyond: a position statement of the European expert panel for testosterone research","volume":"13","author":"Zitzmann","year":"2025","journal-title":"Andrology"},{"issue":"2","key":"10.1016\/j.maturitas.2026.108870_bb0180","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1210\/jc.2017-02243","article-title":"The effect of testosterone on cardiovascular biomarkers in the testosterone trials","volume":"103","author":"Mohler","year":"2018","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"11","key":"10.1016\/j.maturitas.2026.108870_bb0185","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1016\/j.mayocp.2024.08.008","article-title":"Androgen society position paper on cardiovascular risk with testosterone therapy","volume":"99","author":"Morgentaler","year":"2024","journal-title":"Mayo Clin. Proc."},{"issue":"8","key":"10.1016\/j.maturitas.2026.108870_bb0190","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1111\/andr.13626","article-title":"TRACK_9: Testosterone replacement assessment: classical vs. functional hypogonadism \u2013 knowledge from a 9-year study","volume":"12","author":"Zitzmann","year":"2024","journal-title":"Andrology"},{"issue":"1","key":"10.1016\/j.maturitas.2026.108870_bb0195","doi-asserted-by":"crossref","DOI":"10.1080\/13685538.2024.2357548","article-title":"Testosterone therapy over 60 months improves aging male symptoms scores in all men with adult-onset testosterone deficiency","volume":"27","author":"Haider","year":"2024","journal-title":"Aging Male"},{"issue":"10","key":"10.1016\/j.maturitas.2026.108870_bb0200","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.40030","article-title":"Efficacy of testosterone replacement therapy in correcting anemia in men with hypogonadism: a randomized clinical trial","volume":"6","author":"Pencina","year":"2023","journal-title":"JAMA Netw. Open"},{"issue":"2","key":"10.1016\/j.maturitas.2026.108870_bb0205","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1210\/clinem\/dgad484","article-title":"Effect of testosterone replacement therapy on sexual function and hypogonadal symptoms in men with hypogonadism","volume":"109","author":"Pencina","year":"2024","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"7","key":"10.1016\/j.maturitas.2026.108870_bb0210","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1210\/clinem\/dgae026","article-title":"Depressive syndromes in men with hypogonadism in the TRAVERSE trial: response to testosterone-replacement therapy","volume":"109","author":"Bhasin","year":"2024","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.maturitas.2026.108870_bb0215","series-title":"FDA Drug Safety Communication: FDA cautions about using testosterone products for low testosterone due to aging; requires labeling change to inform of possible increased risk of heart attack and stroke with use","year":"2025"},{"key":"10.1016\/j.maturitas.2026.108870_bb0220","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ahj.2025.04.004","article-title":"Association of testosterone-induced increase in neutrophil and monocyte counts with thromboembolic events: the TRAVERSE trial","volume":"288","author":"Gagliano-Juc\u00e1","year":"2025","journal-title":"Am. Heart J."},{"issue":"3","key":"10.1016\/j.maturitas.2026.108870_bb0225","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1056\/NEJMoa2308836","article-title":"Testosterone treatment and fractures in men with hypogonadism","volume":"390","author":"Snyder","year":"2024","journal-title":"N. Engl. J. Med."},{"issue":"8","key":"10.1016\/j.maturitas.2026.108870_bb0230","doi-asserted-by":"crossref","first-page":"e3143","DOI":"10.1210\/clinem\/dgab149","article-title":"Effect of testosterone treatment on bone microarchitecture and bone mineral density in men: a 2-year RCT","volume":"106","author":"Ng Tang Fui","year":"2021","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"10","key":"10.1016\/j.maturitas.2026.108870_bb0235","doi-asserted-by":"crossref","first-page":"3666","DOI":"10.1210\/jcem.84.10.6079","article-title":"A critical evaluation of simple methods for the estimation of free testosterone in serum","volume":"84","author":"Vermeulen","year":"1999","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"9","key":"10.1016\/j.maturitas.2026.108870_bb0240","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/j.jsxm.2017.07.004","article-title":"Wheaton OA; RHYME investigators. Quality of life and sexual function benefits of long-term testosterone treatment: longitudinal results from the registry of hypogonadism in men (RHYME)","volume":"14","author":"Rosen","year":"2017","journal-title":"J. Sex. Med."},{"issue":"2","key":"10.1016\/j.maturitas.2026.108870_bb0245","doi-asserted-by":"crossref","first-page":"105","DOI":"10.7326\/M19-0830","article-title":"Efficacy and Safety of testosterone treatment in men: an evidence report for a clinical practice guideline by the American College of Physicians","volume":"172","author":"Diem","year":"2020","journal-title":"Ann. Intern. Med."},{"issue":"10","key":"10.1016\/j.maturitas.2026.108870_bb0250","doi-asserted-by":"crossref","first-page":"e561","DOI":"10.1016\/S2666-7568(23)00169-1","article-title":"Symptomatic benefits of testosterone treatment in patient subgroups: a systematic review, individual participant data meta-analysis, and aggregate data meta-analysis","volume":"4","author":"Hudson","year":"2023","journal-title":"Lancet Healthy Longev."},{"key":"10.1016\/j.maturitas.2026.108870_bb0255","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1056\/NEJMoa1506119","article-title":"Testosterone trials investigators. Effects of testosterone treatment in older men","volume":"374","author":"Snyder","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.maturitas.2026.108870_bb0260","doi-asserted-by":"crossref","first-page":"198","DOI":"10.3109\/13685538.2012.699562","volume":"15","author":"Behre","year":"2012","journal-title":"Aging Male"},{"key":"10.1016\/j.maturitas.2026.108870_bb0265","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.aju.2015.10.002","article-title":"Testosterone replacement therapy improves the health-related quality of life of men diagnosed with late-onset hypogonadism","volume":"14","author":"Almehmadi","year":"2016","journal-title":"Arab. J. Urol."},{"key":"10.1016\/j.maturitas.2026.108870_bb0270","doi-asserted-by":"crossref","first-page":"25","DOI":"10.4103\/1008-682X.148720","article-title":"Effects of long-term androgen replacement therapy on the physical and mental statuses of aging males with late-onset hypogonadism: a multicenter randomized controlled trial in Japan (EARTH study)","volume":"18","author":"Konaka","year":"2016","journal-title":"Asian J. Androl."},{"key":"10.1016\/j.maturitas.2026.108870_bb0275","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1210\/clinem\/dgae085","article-title":"Testosterone treatment, weight loss, and health-related quality of life and psychosocial function in men: a 2-year randomized controlled trial","volume":"109","author":"Grossmann","year":"2024","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.maturitas.2026.108870_bb0280","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1016\/j.jsxm.2016.05.010","article-title":"Demographic and clinical correlates of patient-reported improvement in sex drive, erectile function, and energy with testosterone solution 2","volume":"13","author":"Wu","year":"2016","journal-title":"J. Sex. Med."}],"container-title":["Maturitas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378512226000472?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378512226000472?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T14:56:39Z","timestamp":1792508199000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378512226000472"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":56,"alternative-id":["S0378512226000472"],"URL":"https:\/\/doi.org\/10.1016\/j.maturitas.2026.108870","relation":{},"ISSN":["0378-5122"],"issn-type":[{"value":"0378-5122","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Functional testosterone deficiency in aging men: Clinical impact, diagnostic pathways, and treatment strategies","name":"articletitle","label":"Article Title"},{"value":"Maturitas","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.maturitas.2026.108870","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"108870"}}